Ticker Details
Aquestive Therapeutics, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$508.93M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.67%
Avg Daily Range (30 D):	$0.09 | 2.26%
Avg Daily Range (90 D):	$0.12 | 2.70%

Institutional Daily Volume
Avg Daily Volume:	.95M
Avg Daily Volume (30 D):	1.62M
Avg Daily Volume (90 D):	3.41M

Trade Size
Avg Trade Size (Sh.):	179
Avg Trade Size (Sh.) (30 D):	127
Avg Trade Size (Sh.) (90 D):	172

Institutional Trades
Total Institutional Trades:	295
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$1.4M
Avg Institutional Trade (90 D):	$1.28M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.56M
Avg Closing Trade (30 D):	$1.17M
Avg Closing Trade (90 D):	$1.21M
Avg Closing Volume:	333.89K

News

Apr 10, 2026 @ 10:48 PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestiv... Source: Rosen Law Firm

Apr 10, 2026 @ 10:31 PM FBRT DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUN... Source: Rosen Law Firm

Apr 6, 2026 @ 8:52 PM Holzer & Holzer, LLC Reminds Investors of Lead Pla... Source: Holzer & Holzer, Llc

Apr 6, 2026 @ 8:00 PM AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. ... Source: Levi & Korsinsky, Llp

Apr 6, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Aquestive ... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.78	$-.27	$-.78
Diluted EPS	$-.78	$-.27	$-.78
Revenue	$44.55M	$13.02M	$44.55M
Gross Profit	$25.99M	$7.18M	$25.99M
Net Income / Loss	$-83.78M	$-31.86M	$-83.78M
Operating Income / Loss	$-71.05M	$-28.84M	$-71.05M
Cost of Revenue	$18.56M	$5.84M	$18.56M
Net Cash Flow	$49.62M	$-7.89M	$49.62M
PE Ratio